Quarterly report · Q2
7634.TEDINET S100PKVO
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥12.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥806m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥613m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥625m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥627m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥560m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥421m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥564m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥426m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥20.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥20.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥19.3bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥14.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.9bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥816m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥902m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥230m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥690m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥240m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥483m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥937m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥455m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥180.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥105.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥358.33 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.39 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.45 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥84m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥402m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥588m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥545m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥193m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥19m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥721m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥806m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥654m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥654m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥86m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥418m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥418m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥19m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥217m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥326m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥281m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥42m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥244m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥181m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥181m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥4m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥5.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥5.3bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥527m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥613m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 489
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)小池酸素工業株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)東京都墨田区太平三丁目４番８号 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)株主としての権利内容に制限のない、標準となる株式 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)同上 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)同上 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社星医療酸器 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都足立区入谷七丁目11番18号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding inventories (text) | CurrentQuarterInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |